Hunter J. Shkolnik specializes in the trial of significant personal injury cases primarily in the area of medical malpractice and product liability. He was class counsel in a major ERISA action brought by chiropractors against Empire Blue Cross and Blue Shield. He is a member of the Plaintiff's Steering Committee and a lead counsel in the N.Y. Diet Drug/Phen-Fen litigation; a member of the Plaintiff's Steering Committee and a lead counsel in the N.Y. Sulzer Inter-Op Hip and Knee Implant litigation;Plaintiff Steering Committee MDL#1708- Guidant Products Litigation; MDL#1726- In Re Medtronics, Inc. Implant Defibrillator Poduct Liability Litigation;  he is both an Assistant Treasurer and on the Board of Directors of the New York State Trial Lawyers (NYSTLA);  Past-President of the Long Island Affiliate of the NYSTLA; past member the Medical Malpractice Committee of the Association of the Bar of the City of New York; past Vice Chairman of the Medical Legal Committee of the Nassau County Bar Association; and is past Vice- Chairman of the ATLA Health Care Finance Litigation Group; Vice-Chairman and Science Committee Director of the ATLA Orthopedic Implant Litigation Group; Chairman of the ATLA Breast Cancer Litigation Group; Co-Chair ATLA Heart Device Litigation Group. Hunter has lectured extensively in the areas of medical malpractice, medical device, auto product and drug product liability. For the last four years he has been the moderator and speaker at the ATLA Breast Cancer Litigation Group Educational Seminar on Breast Cancer Litigation. Recently, Hunter has become an co-author and presenter at NYSTLA's Decisions Program writing and speaking on New York product liability Law.  Hunter can be e-mailed directly at hshkolnik@rheingoldlaw.com.